Related Experiment Video
Updated: Sep 23, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
Published on: May 23, 2021
Colchicine use in the damaged disk syndrome (DDS). Report of 50 patients
Abstract:
Fifty patients with acute and chronic damaged disk syndromes responded (68% good or excellent results) to minimal colchicine usage (0.6 to 1.2 mg per day), indicating that more complicated measures may be avoided in many distressed patients who suffer from disk disease. The usefulness of colchicine is slightly better in the acute than in the chronic disk syndrome, but any disk-suffering patient deserves a therapeutic trial of this possibly valuable medicament, before progressing to more complex, invasive procedures.
Related Concept Videos
Drugs that Destabilize Microtubules
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

